Refeyn, the pioneer of mass photometry technology, is continuing to strengthen the deployment of its unique bioanalytical tools with the planned Grand Opening of its new US Headquarters and Customer Interaction Center, in conjunction with the third annual Mass Photometry Summit 2024. Following the summit, highlighting the very latest advances in mass photometry, to be held in the Boston area on May 22, Refeyn will officially open its new 10,000 sq. ft. HQ in the heart of Waltham’s Biotech Hub in Greater Boston, Massachusetts, on May 23.
Ipsen’s Iqirvo wins European approval for primary biliary cholangitis – Pharmaceutical Technology
The decision in Europe follows an accelerated approval by the FDA earlier this year. Image credit: Shutterstock / Ekaterina Markelova. The European Commission (EC) has
September 23, 2024